These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 21218073)

  • 1. Simultaneous spectrophotometric estimation of tenofovir disoproxil fumarate and Lamivudine in three component tablet formulation containing efavirenz.
    Sharma R; Mehta K
    Indian J Pharm Sci; 2010 Jul; 72(4):527-30. PubMed ID: 21218073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous Spectrophotometric Method for Determination of Emtricitabine and Tenofovir Disoproxil Fumarate in Three-Component Tablet Formulation Containing Rilpivirine Hydrochloride.
    Venkatesan S; Kannappan N
    Int Sch Res Notices; 2014; 2014():541727. PubMed ID: 27379309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spectrophotometric simultaneous determination of Tenofovir disoproxil fumarate and Emtricitabine in combined tablet dosage form by ratio derivative, first order derivative and absorbance corrected methods and its application to dissolution study.
    Choudhari VP; Ingale S; Gite SR; Tajane DD; Modak VG; Ambekar A
    Pharm Methods; 2011 Jan; 2(1):47-52. PubMed ID: 23781430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RP-HPLC method for simultaneous estimation of tenofovir disoproxil fumarate, lamivudine, and efavirenz in combined tablet dosage form.
    Bhavsar DS; Patel BN; Patel CN
    Pharm Methods; 2012 Jul; 3(2):73-8. PubMed ID: 23781482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A simple stability indicating RP-HPLC-DAD method for concurrent analysis of Tenofovir Disoproxil Fumarate, Doravirine and Lamivudine in pure blend and their combined film coated tablets.
    Godela R; Gummadi S
    Ann Pharm Fr; 2021 Nov; 79(6):640-651. PubMed ID: 34019910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simple thin layer chromatography-ultraviolet spectrophotometric method for quality assessment of binary fixed-dose-combinations of lamivudine/tenofovir disoproxil fumarate and lamivudine/zidovudine in tablet formulations.
    Vaikosen EN; Kashimawo AJ; Soyinka JO; Orubu S; Elei S; Ebeshi BU
    J Sep Sci; 2020 Jun; 43(11):2228-2239. PubMed ID: 32125772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A simple alternative and improved HPLC method for the estimation of doravirine, lamivudine, and tenofovir disoproxil fumarate in solid oral dosage form.
    Kokkirala TK; Kancherla P; Alegete P; Suryakala D
    Biomed Chromatogr; 2021 Aug; 35(8):e5121. PubMed ID: 33760252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of fixed-dose combination of tenofovir disoproxil fumarate, lamivudine, and efavirenz: results of a randomized, crossover, bioequivalence study.
    Abhyankar D; Shedage A; Gole M; Raut P
    Int J STD AIDS; 2017 Apr; 28(5):491-498. PubMed ID: 27317878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of UV-spectrophotometric methods for estimation of tenofovir disoproxil fumarate in tablets.
    A SA; H BC; J SS
    Pak J Pharm Sci; 2009 Jan; 22(1):27-9. PubMed ID: 19168416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Switching from efavirenz, emtricitabine, and tenofovir disoproxil fumarate to tenofovir alafenamide coformulated with rilpivirine and emtricitabine in virally suppressed adults with HIV-1 infection: a randomised, double-blind, multicentre, phase 3b, non-inferiority study.
    DeJesus E; Ramgopal M; Crofoot G; Ruane P; LaMarca A; Mills A; Martorell CT; de Wet J; Stellbrink HJ; Molina JM; Post FA; Valero IP; Porter D; Liu Y; Cheng A; Quirk E; SenGupta D; Cao H
    Lancet HIV; 2017 May; 4(5):e205-e213. PubMed ID: 28259776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emtricitabine/tenofovir disoproxil fumarate.
    Drugs R D; 2004; 5(3):160-1. PubMed ID: 15139777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dolutegravir with emtricitabine and tenofovir alafenamide or tenofovir disoproxil fumarate versus efavirenz, emtricitabine, and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection (ADVANCE): week 96 results from a randomised, phase 3, non-inferiority trial.
    Venter WDF; Sokhela S; Simmons B; Moorhouse M; Fairlie L; Mashabane N; Serenata C; Akpomiemie G; Masenya M; Qavi A; Chandiwana N; McCann K; Norris S; Chersich M; Maartens G; Lalla-Edward S; Vos A; Clayden P; Abrams E; Arulappan N; Hill A
    Lancet HIV; 2020 Oct; 7(10):e666-e676. PubMed ID: 33010240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiretroviral drugs for prevention of mother-to-child transmission: pharmacologic considerations for a public health approach.
    Lamorde M; Schapiro JM; Burger D; Back DJ
    AIDS; 2014 Nov; 28(17):2551-63. PubMed ID: 25574958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacokinetics, pharmacodynamics, and clinical role of fixed dose combination of tenofovir disoproxil fumarate, lamivudine and reduced dose efavirenz (TLE-400) in treating HIV-1 infection.
    Dubrocq G; Rakhmanina N
    Expert Opin Drug Metab Toxicol; 2018 Aug; 14(8):773-779. PubMed ID: 29985071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Derivative spectrophotometric method for estimation of antiretroviral drugs in fixed dose combinations.
    P B M; R B P; S G K
    Adv Pharm Bull; 2012; 2(1):115-8. PubMed ID: 24312779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efavirenz/emtricitabine/tenofovir disoproxil fumarate single-tablet regimen (Atripla®): a review of its use in the management of HIV infection.
    Deeks ED; Perry CM
    Drugs; 2010 Dec; 70(17):2315-38. PubMed ID: 21080746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efavirenz/emtricitabine/tenofovir disoproxil fumarate: triple combination tablet.
    Frampton JE; Croom KF
    Drugs; 2006; 66(11):1501-12; discussion 1513-4. PubMed ID: 16906786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early virologic nonresponse to tenofovir, abacavir, and lamivudine in HIV-infected antiretroviral-naive subjects.
    Gallant JE; Rodriguez AE; Weinberg WG; Young B; Berger DS; Lim ML; Liao Q; Ross L; Johnson J; Shaefer MS;
    J Infect Dis; 2005 Dec; 192(11):1921-30. PubMed ID: 16267763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The New NNRTI ACC007 Combined with Lamivudine and Tenofovir Disoproxil Fumarate Show Synergy Anti-HIV Activity In Vitro.
    Huang XS; Luo RH; Hu XL; Chen H; Xiang SY; Tang CR; Zhang CT; Shen XN; Zheng YT
    Curr HIV Res; 2020; 18(5):332-341. PubMed ID: 32562524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV.
    Gallant JE; DeJesus E; Arribas JR; Pozniak AL; Gazzard B; Campo RE; Lu B; McColl D; Chuck S; Enejosa J; Toole JJ; Cheng AK;
    N Engl J Med; 2006 Jan; 354(3):251-60. PubMed ID: 16421366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.